It hardly seems fair but people who are attractive because of one trait tend to have other attractive traits as well.
It’s a simple fact: some individuals are more attractive to the opposite sex than others. But what makes them more desirable?
Researchers have found that the SLIRP gene - discovered at the Western Australian Institute for Medical Research (WAIMR) and known to affect hormone action in breast and prostate cancer cells - has an impact on male fertility.
Scientists have begun to understand how the rest of the genome interacts with mutations, explaining why not everyone with identical genetic mutations develops a disease.
Genome-TALER Human AAVS1 Safe Harbor Knock-in ORF Clones from GeneCopoeia are constructed for specifically transferring the ORF of interest from a donor plasmid into the AAVS1 safe harbour site in human chromosome 19 using the Genome-TALER Human AAVS1 Safe Harbor Gene Knock-in Kit.
Researchers have found that rather than just one mutation causing enhanced survival, about five to seven mutations are required. These extra mutations are termed ‘genetic hitchhikers’ because they don’t appear to contribute to the enhanced fitness of the organism.
A method has been developed that can rapidly identify pathogenic species and strains causing illnesses, such as pneumonia. This could help lead to earlier detection of disease outbreaks and pinpoint effective treatments more quickly.
Life Technologies’ Ion AmpliSeq Exome Kit delivers very good exome sequencing performance, with up to 98% of bases covered at 10x, and up to 96% of bases covered at 20x, for a single exome.
A new experimental technique allows users to study the function of individual proteins in individual cell types in a living organism.
The MRC-NIHR Phenome Centre, opened on 5 June, is the world’s first large-scale national phenomics facility. It will help scientists and doctors better understand how the interaction between a person’s genes and the environment (phenomics) affects that person’s susceptibility to various diseases.
Next Generation Sequencing (NGS) is generating key medical discoveries at a rate that far exceeds our ability to translate them into robust clinical assays. New enzyme-free, digital, highly multiplexed gene-expression technology (eg, the nCounter platform by NanoString) has the three key characteristics required to accelerate translation of genomic discoveries into robust clinical assays.
PathoGenetix, a commercial-stage developer of an automated system for rapid bacterial identification, has announced research demonstrating the use of genome sequence scanning (GSS) technology to confirm and identify pathogenic Salmonella strains in enriched spinach samples in less than 5 h.
The brain acts as a timekeeper for each cell’s 24-hour body clock, keeping this clock in sync with the world so that it can govern our appetites, sleep, moods and more. But new research shows that the clock may be broken in the brain cells of people with depression, meaning they operate out of sync with the usual ingrained daily cycle.
A global team of researchers has identified the gene behind an Australian toddler’s paediatric brain disorder in a discovery that is paving the way for the diagnosis and treatment of other children with genetic diseases.
New evidence elucidates the mystery of the genetic basis of Tourette syndrome (TS) that has puzzled medical researchers for over a century. This remarkable discovery linking genes, brain, mind and behaviour provides unparalleled insight into the biological basis of human behaviour.